Peer-reviewedCC BYBiomedicines
Proteomic and Metabolomic Analyses of Lung Squamous Cell Carcinoma
4 affiliations
- 1Cardiothoracic Surgery, Shenzhen Hospital, , Shenzhen 518100, China; (Y.M.); (J.Z.)
- 2School of Nursing, , Guangzhou 510520, China;
- 3Institute of Toxicology, , Guangzhou 511430, China
- 4Department of Toxicology, School of Public Health, , Guangzhou 510080, China
Related
- Epimedium koreanum Nakai attenuates glucocorticoid-induced osteoporosis by suppressing ferroptosis via the KEAP1/NRF2/SLC7A11/GPX4 axis: comparative pharmacodynamic evaluation of four epimedium species and proteomic and metabolomic analyses of epk
- Integrated transcriptomic and metabolomic analyses identify key metabolites and genes in sepsis-associated acute lung injury
- Unexpected Pericardial Cytology in a Patient With Primary Squamous Cell Carcinoma of the Lung: Emphasizing the Need for Advanced Molecular Characterization of Tumors
- TNIK maintains a MYC-driven partial EMT state that supports proliferation and evasion of senescence in lung squamous cell carcinoma.
- Therapeutic Impact of Third-generation Tyrosine Kinase Inhibitors on Lung Squamous Cell Carcinoma with Epidermal Growth Factor Receptor Mutations: A Case Description and Systematic Literature Review
BibTeX
@article{mo2026proteomic,
title = {{Proteomic and Metabolomic Analyses of Lung Squamous Cell Carcinoma}},
author = {Yijun Mo and Lina Lin and Jianhua Zhang and Qing Li and Daochuan Li},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702009},
note = {CC BY},
}
RIS
TY - JOUR
TI - Proteomic and Metabolomic Analyses of Lung Squamous Cell Carcinoma
AU - Yijun Mo
AU - Lina Lin
AU - Jianhua Zhang
AU - Qing Li
AU - Daochuan Li
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13702009
SN - 2227-9059
ER -